7.22
Profusa Inc stock is traded at $7.22, with a volume of 262.07K.
It is down -5.94% in the last 24 hours and down -11.00% over the past month.
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
See More
Previous Close:
$7.57
Open:
$6.65
24h Volume:
262.07K
Relative Volume:
0.18
Market Cap:
$1.82M
Revenue:
$75,000
Net Income/Loss:
$-42.41M
P/E Ratio:
-0.0402
EPS:
-179.8206
Net Cash Flow:
$-18.47M
1W Performance:
+97.82%
1M Performance:
-11.00%
6M Performance:
+23.61%
1Y Performance:
-94.91%
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PFSA
Profusa Inc
|
7.20 | 3.44M | 75,000 | -42.41M | -18.47M | -179.82 |
|
ABT
Abbott Laboratories
|
115.73 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.00 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.61 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.87 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.91 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Stock (PFSA) Latest News
Profusa net hits USD 8.8M in Q2 2026 - Medical Buyer
Profusa Announces Q2 2026 Financial Results a - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Profusa, Inc. Common Stock (NASDAQ: PFSA) Share Price, PFSA Stock News, PFSA Share Price & Updates - kalkine.ca
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens - Yahoo Finance
Profusa Reports Q2 Net Loss Widens to $8.8M Amid G3 Option Deal Progress - Minichart
Profusa converts $4.6M debt to preferred stock ahead of G3 deal - Investing.com
Profusa reports Q2 2026 net loss of $8.8M; stockholders’ equity expected $28.4M after option agreement - TradingView
Profusa Announces Q2 2026 Financial Results and Progress on - GlobeNewswire
PFSA Stock Quote Price and Forecast - CNN
Profusa Company Profile & Introduction - Moomoo
Profusa (PFSA) CFO converts $1.29M note into 302K shares at $4.28 - Stock Titan
Profusa (PFSA) sponsor’s $1.3M debt swap nears half the stock - Stock Titan
Profusa (PFSA) CEO turns $1.29M note into 301,991 shares - Stock Titan
NorthView Sponsor I, LLC Discloses Investment at Profusa, Inc. with 49.9% Stake - TradingView
Profusa Cash Drops to $719K, Digital Assets Eliminated - Minichart
Profusa, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
HRT Financial LP sells $109,266 of Profusa stock By Investing.com - Investing.com India
HRT Financial LP sells $109,266 of Profusa stock - Investing.com
Profusa (PFSA) 10% holder cuts direct stake to zero - Stock Titan
Mercury Systems Posts Mixed Q4 Results, Joins WhiteFiber And Other Big Stocks Moving Lower In Wednesday’s - Benzinga
Nasdaq Down Over 1%; Home Depot Earnings Top Estimates - Sahm
Profusa announces special shareholder meeting - Bitget
Profusa Stock Fall 35% After Hours Following 500% Intraday SurgeProfusa (NASDAQ:PFSA) - Benzinga
Profusa, Baidu, Amylyx Pharmaceuticals, FreeCast and Klarna Group: Why These 5 Stocks Are on Investors' R - Benzinga
Profusa, Baidu, Amylyx Pharmaceuticals, FreeCast and Klarna Group: Why These 5 Stocks Are on Investors' Radars Today - TradingView
Profusa (NASDAQ: PFSA) 10% owner sells 3,163 shares - Stock Titan
Profusa (PFSA) Share-Price Review: Gains 179.25% to Reach $12.65; Level Position: the Session Ends Within the Reported Technical Boundaries in the Latest ReadingUp Down Volume - Vinanet
Trending Stocks Today | Profusa Soars 251.65% - Moomoo
Profusa (PFSA) Stock Sinks After Diagnostics Deal News - timothysykes.com
Profusa (PFSA) Stock Soars 96% Following Third Reverse Split in 2026 - Blockonomi
Profusa (PFSA) Slides 18% As Traders Question New Acquisition Deal - StocksToTrade
Profusa (PFSA) Slides 18% As Acquisition Plan Rattles Traders - StocksToTrade
Amylyx, Duolingo and Profusa jump premarket, Baidu falls after Q2 results - Investing.com South Africa
Why is Profusa stock surging today? - Investing.com
Why is Profusa stock surging today? By Investing.com - Investing.com India
After-Hours Gainers: PFSA Executes Another Reverse Split, IVF Jumps On Q2 Results, AMLX Faces D-Day - RTTNews
HRT Financial LP sells Profusa shares for $1,234 By Investing.com - Investing.com South Africa
HRT Financial sells $2,211 in Profusa (PFSA) shares By Investing.com - Investing.com India
HRT Financial sells $2,211 in Profusa (PFSA) shares - Investing.com
PFSA: PROFUSA, Inc.Comparative Chart - Zacks Investment Research
HRT Financial LP Trims Profusa Inc (PFSA) Stake in Recent 13DG F - GuruFocus
Profusa, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Profusa Inc. (PFSA) Dips 3.66% to $0.90 as Shares Approach Key Support ZoneLow Beta Factor - Vinanet
Profusa (PFSA) 10% owner HRT FINANCIAL reports net sale of 36,826 shares - Stock Titan
Profusa announces reverse stock split - Medical Buyer
Form 8K Profusa Inc For: 14 August By Investing.com - Investing.com Nigeria
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company - ADVFN
Profusa Inc. (PFSA) Slips 4.42% to $0.92 as Support Test LoomsFair Value Gap - Vinanet
Enterprise value to EBIT forward of PROFUSA, INC. – OTC:NVACW - TradingView
Profusa Inc Stock (PFSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Profusa Inc Stock (PFSA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Aug 14 '26 |
Sale |
0.90 |
3,163 |
2,853 |
71,035 |
| HRT FINANCIAL LP | 10% Owner |
Aug 12 '26 |
Buy |
0.96 |
5,585 |
5,384 |
116,609 |
| HRT FINANCIAL LP | 10% Owner |
Aug 13 '26 |
Sale |
0.89 |
42,411 |
37,661 |
74,198 |
| HRT FINANCIAL LP | 10% Owner |
Aug 10 '26 |
Buy |
0.94 |
4,016 |
3,791 |
113,304 |
| HRT FINANCIAL LP | 10% Owner |
Aug 11 '26 |
Sale |
0.97 |
2,280 |
2,212 |
111,024 |
| HRT FINANCIAL LP | 10% Owner |
Aug 06 '26 |
Buy |
0.94 |
926 |
873 |
110,212 |
| HRT FINANCIAL LP | 10% Owner |
Aug 07 '26 |
Sale |
0.95 |
924 |
874 |
109,288 |
| HRT FINANCIAL LP | 10% Owner |
Aug 05 '26 |
Sale |
0.94 |
383 |
361 |
109,286 |
| HRT FINANCIAL LP | 10% Owner |
Aug 03 '26 |
Buy |
0.96 |
14,556 |
13,945 |
108,301 |
| HRT FINANCIAL LP | 10% Owner |
Aug 04 '26 |
Buy |
0.95 |
1,368 |
1,305 |
109,669 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):